First Horizon Advisors Inc. Has $1.15 Million Stake in CME Group Inc. (NASDAQ:CME)

First Horizon Advisors Inc. trimmed its holdings in CME Group Inc. (NASDAQ:CME) by 5.0% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 5,206 shares of the financial services provider’s stock after selling 273 shares during the quarter. First Horizon Advisors Inc.’s holdings in CME Group were worth $1,149,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of CME. Y.D. More Investments Ltd acquired a new position in CME Group during the second quarter worth approximately $36,000. McClarren Financial Advisors Inc. lifted its position in shares of CME Group by 66.1% in the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock worth $39,000 after purchasing an additional 78 shares during the period. Asset Dedication LLC grew its position in shares of CME Group by 515.2% during the 2nd quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock worth $40,000 after buying an additional 170 shares during the period. Thurston Springer Miller Herd & Titak Inc. raised its position in shares of CME Group by 62.2% during the third quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock worth $43,000 after purchasing an additional 74 shares during the period. Finally, Bank & Trust Co bought a new position in CME Group during the 2nd quarter valued at $76,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts recently commented on the company. Royal Bank of Canada restated a “sector perform” rating and set a $235.00 target price on shares of CME Group in a research report on Thursday, October 24th. Deutsche Bank Aktiengesellschaft decreased their target price on CME Group from $227.00 to $226.00 and set a “hold” rating for the company in a report on Monday, November 11th. Oppenheimer lifted their price target on CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a research report on Thursday, October 24th. Morgan Stanley raised their target price on shares of CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a research note on Thursday, October 17th. Finally, Bank of America upped their target price on shares of CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a research note on Thursday, October 3rd. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $224.47.

Insider Buying and Selling

In other news, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction that occurred on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the sale, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. The trade was a 5.38 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Timothy Francis Mccourt sold 1,374 shares of the stock in a transaction dated Monday, October 28th. The stock was sold at an average price of $227.12, for a total value of $312,062.88. Following the transaction, the insider now directly owns 7,275 shares in the company, valued at approximately $1,652,298. The trade was a 15.89 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 15,621 shares of company stock worth $3,441,063. 0.30% of the stock is owned by corporate insiders.

CME Group Stock Down 0.5 %

CME stock opened at $226.96 on Friday. The firm has a 50-day simple moving average of $223.40 and a 200-day simple moving average of $210.92. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $230.74. The stock has a market capitalization of $81.79 billion, a P/E ratio of 23.87, a P/E/G ratio of 5.30 and a beta of 0.55. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.65 by $0.03. The company had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The firm’s quarterly revenue was up 18.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.25 EPS. Equities analysts forecast that CME Group Inc. will post 10.22 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Monday, December 9th will be issued a $1.15 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $4.60 annualized dividend and a dividend yield of 2.03%. CME Group’s dividend payout ratio is presently 48.37%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.